A review of 6 placebo-managed scientific trials with one,134 complete individuals concluded that cannabinoids (nabiximols, dronabinol, and THC/CBD) have been related to a higher normal enhancement to the Ashworth scale for spasticity in several sclerosis patients as opposed with placebo, Despite the fact that this did not achieve statistical significance. https://ralphj073dxr2.blog-gold.com/profile